IL18 and macrophage activation syndrome: Therefore, the use of IL-18BP, a natural antagonist of IL-18, or an anti-IL-18 neutralizing antibody should be investigated in sJIA-associated MAS, as this type of MAS is characterized by the positive correlation of the IL-18 level with NK cell dysfunction, which is not observed in fHLH48.